Eddy S. Yang

Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.

Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.

Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.

Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.

The role of mTOR inhibition in augmenting radiation induced autophagy.

Evolution of clinical trials in head and neck cancer.

Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.

Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.

Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.

Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy.

BRCA1 16 years later: DNA damage-induced BRCA1 shuttling.

DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.

Glycogen synthase kinase 3beta inhibition enhances repair of DNA double-strand breaks in irradiated hippocampal neurons.

Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.

The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.

Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.

Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study.

p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.

Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.

Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors.

Kinomic profiling approach identifies Trk as a novel radiation modulator.

MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.

Epigenetic inactivation of DNA repair in breast cancer.

Targeting BRCA1 Localization to Augment Breast Tumor Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition.

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.

HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.

Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.

Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer.